168 related articles for article (PubMed ID: 25695055)
1. Acupuncture may exert its therapeutic effect through microRNA-339/Sirt2/NFκB/FOXO1 axis.
Wang JY; Li H; Ma CM; Wang JL; Lai XS; Zhou SF
Biomed Res Int; 2015; 2015():249013. PubMed ID: 25695055
[TBL] [Abstract][Full Text] [Related]
2. Sirt2 suppresses glioma cell growth through targeting NF-κB-miR-21 axis.
Li Y; Dai D; Lu Q; Fei M; Li M; Wu X
Biochem Biophys Res Commun; 2013 Nov; 441(3):661-7. PubMed ID: 24161395
[TBL] [Abstract][Full Text] [Related]
3. Adenosine as a probing tool for the mechanistic study of acupuncture treatment.
Wang JY; Li H; Zhang L; Ma CM; Wang JL; Lai XS; Zhou SF
Clin Exp Pharmacol Physiol; 2014 Nov; 41(11):933-9. PubMed ID: 25199539
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a.
Gao F; Wang W
Mol Med Rep; 2015 Feb; 11(2):1200-6. PubMed ID: 25369914
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
Baer C; Oakes CC; Ruppert AS; Claus R; Kim-Wanner SZ; Mertens D; Zenz T; Stilgenbauer S; Byrd JC; Plass C
Int J Cancer; 2015 Sep; 137(6):1352-61. PubMed ID: 25704289
[TBL] [Abstract][Full Text] [Related]
6. SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation.
Jing E; Gesta S; Kahn CR
Cell Metab; 2007 Aug; 6(2):105-14. PubMed ID: 17681146
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.
Xu Y; Zhao S; Cui M; Wang Q
Int J Clin Exp Pathol; 2015; 8(9):10294-304. PubMed ID: 26617737
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic miR-9 is a target of erlotinib in NSCLCs.
Chen X; Zhu L; Ma Z; Sun G; Luo X; Li M; Zhai S; Li P; Wang X
Sci Rep; 2015 Nov; 5():17031. PubMed ID: 26593208
[TBL] [Abstract][Full Text] [Related]
10. MiR-339 is a potential biomarker of coronary heart disease to aggravate oxidative stress through Nrf2/FOXO3 targeting Sirt2.
Shi L; Zhang Y; Zhang J; Gao Y; Liu J; Chen M; Yang X
Ann Palliat Med; 2021 Mar; 10(3):2596-2609. PubMed ID: 33849089
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
12. Human-specific microRNA regulation of FOXO1: implications for microRNA recognition element evolution.
McLoughlin HS; Wan J; Spengler RM; Xing Y; Davidson BL
Hum Mol Genet; 2014 May; 23(10):2593-603. PubMed ID: 24368418
[TBL] [Abstract][Full Text] [Related]
13. De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease.
Wong HK; Veremeyko T; Patel N; Lemere CA; Walsh DM; Esau C; Vanderburg C; Krichevsky AM
Hum Mol Genet; 2013 Aug; 22(15):3077-92. PubMed ID: 23585551
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of microRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1.
Li F; Liu B; Gao Y; Liu Y; Xu Y; Tong W; Zhang A
FEBS Lett; 2014 Feb; 588(4):538-44. PubMed ID: 24374340
[TBL] [Abstract][Full Text] [Related]
15.
Lu X; Xia H; Jiang J; Xu X; Li M; Chen Z; Sun Y; Zhang H; Yang Z
J Dairy Res; 2020 May; 87(2):232-238. PubMed ID: 32295660
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA profiling in intraocular medulloepitheliomas.
Edward DP; Alkatan H; Rafiq Q; Eberhart C; Al Mesfer S; Ghazi N; Al Safieh L; Kondkar AA; Abu Amero KK
PLoS One; 2015; 10(3):e0121706. PubMed ID: 25807141
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a.
Pacifico F; Crescenzi E; Mellone S; Iannetti A; Porrino N; Liguoro D; Moscato F; Grieco M; Formisano S; Leonardi A
J Clin Endocrinol Metab; 2010 Mar; 95(3):1421-30. PubMed ID: 20061417
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1.
Fan C; Liu S; Zhao Y; Han Y; Yang L; Tao G; Li Q; Zhang L
Biomed Pharmacother; 2013 Jul; 67(6):521-6. PubMed ID: 23721824
[TBL] [Abstract][Full Text] [Related]
19. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
[TBL] [Abstract][Full Text] [Related]
20. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis.
Huang T; Kang W; Zhang B; Wu F; Dong Y; Tong JH; Yang W; Zhou Y; Zhang L; Cheng AS; Yu J; To KF
Mol Cancer; 2016 Jan; 15():9. PubMed ID: 26801246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
